Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.080
+0.089 (8.98%)
At close: Dec 5, 2025, 4:00 PM EST
1.050
-0.030 (-2.76%)
After-hours: Dec 5, 2025, 7:20 PM EST
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $104.94 million as of December 5, 2025. Its market cap has increased by 70.25% in one year.
Market Cap
104.94M
Enterprise Value
83.56M
1-Year Change
70.25%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $104.94M, an increase of 132.97%. That is a compound annual growth rate of 19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 96.29M | 50.00% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |